Literature DB >> 15554430

Microglia.

Denise van Rossum1, Uwe-Karsten Hanisch.   

Abstract

Microglia--the macrophage equivalent of the CNS--safeguards and supports neuronal functions. Threats to the CNS homeostasis can trigger a rapid transformation of these cells from a normally "resting" into alerted and "activated" states. Microglia primarily serves the tissue defence and protection when participating in mechanisms of innate and adaptive immunity. On the contrary, excessive acute or chronic microglial activation can provoke severe neuronal and glial damage by carrying or fuelling destructive cascades. Several factors and conditions have already been identified that maintain the resting phenotype or organize and control the activation process. Cells are thereby able to recognize a dangerous signal as well as to sense functional disturbance. Microglial activation is also proving a much more variable and adaptive process than previously noticed. Aiming at microglia as a therapeutic target, research may focus on intracellular pathways that are probably common to activation scenarios as triggered by various receptor systems. Certain signalling elements may have key roles in the cytosolic integration of sensory inputs and a conversion into programs of executive performance. As the integrative aspect of microglial activation becomes illuminated hope builds up also on strategies for selective interference with harmful outcomes in favour of the--phylogenetically approved--beneficial potential of these fascinating cells.

Entities:  

Mesh:

Year:  2004        PMID: 15554430     DOI: 10.1023/b:mebr.0000043984.73063.d8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  84 in total

Review 1.  Chemokines in the brain: neuroimmunology and beyond.

Authors:  Knut Biber; Mike W Zuurman; Inneke M Dijkstra; Hendrikus W G M Boddeke
Journal:  Curr Opin Pharmacol       Date:  2002-02       Impact factor: 5.547

2.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 3.  Immune function of astrocytes.

Authors:  Y Dong; E N Benveniste
Journal:  Glia       Date:  2001-11       Impact factor: 7.452

Review 4.  Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders.

Authors:  Michal Schwartz
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 5.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 6.  The role of microglia and macrophages in the pathophysiology of the CNS.

Authors:  G Stoll; S Jander
Journal:  Prog Neurobiol       Date:  1999-06       Impact factor: 11.685

7.  Neuronal control of MHC class II inducibility in rat astrocytes and microglia.

Authors:  H Neumann; J Boucraut; C Hahnel; T Misgeld; H Wekerle
Journal:  Eur J Neurosci       Date:  1996-12       Impact factor: 3.386

8.  Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system.

Authors:  K Mertsch; U K Hanisch; H Kettenmann; J Schnitzer
Journal:  J Comp Neurol       Date:  2001-03-05       Impact factor: 3.215

9.  Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function.

Authors:  S Elkabes; E M DiCicco-Bloom; I B Black
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

Review 10.  Inflammatory processes in amyotrophic lateral sclerosis.

Authors:  P L McGeer; E G McGeer
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

View more
  92 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

2.  Neuron-Microglia Dialogue and Hippocampal Neurogenesis in the Aged Brain.

Authors:  Carmelina Gemma; Adam D Bachstetter; Paula C Bickford
Journal:  Aging Dis       Date:  2010-12-01       Impact factor: 6.745

3.  Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.

Authors:  Issam El Ghazi; Wen S Sheng; Shuxian Hu; Brian G Reilly; James R Lokensgard; R Bryan Rock; Phillip K Peterson; George L Wilcox; Ian M Armitage
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-25       Impact factor: 4.147

Review 4.  Microglia biology in health and disease.

Authors:  Gwenn A Garden; Thomas Möller
Journal:  J Neuroimmune Pharmacol       Date:  2006-03-25       Impact factor: 4.147

Review 5.  Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Authors:  Sriram Venneti; Clayton A Wiley; Julia Kofler
Journal:  J Neuroimmune Pharmacol       Date:  2008-12-04       Impact factor: 4.147

Review 6.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

7.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

Review 8.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

9.  PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.

Authors:  Sriram Ramanan; Mitra Kooshki; Weiling Zhao; Fang-Chi Hsu; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2008-09-17       Impact factor: 7.376

10.  N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

Authors:  Douglas McHugh; Sherry S J Hu; Neta Rimmerman; Ana Juknat; Zvi Vogel; J Michael Walker; Heather B Bradshaw
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.